YC Companies/Winter 2021/Entelexo Biotherapeutics
Entelexo Biotherapeutics logo

Entelexo Biotherapeutics

Creating a New Class of Drugs to Address Incurable Autoimmune Diseases

Winter 2021Healthcare / Healthcare -> TherapeuticsIrvine, CA, USA3 employees
Biotech

About

Entelexo is creating modern treatments for immune-mediated diseases, such as psoriasis, using novel engineered exosome technology.

Founders (3)

MILAD RIAZIFAR
Founder
Todd Schurr
Founder
Cameron Taylor
Founder

Details

Status
Active
Stage
Early
Team Size
3
Regions
United States of America, America / Canada